11650sek
-2,3 %
Date:2026-07-10Time:18:00:00Latest report:Q1-2026List:Mid CapTicker:BIOG B
Market Cap:11 785 msekEnterprise Value:10 914 msekNet Sales:1 544 msekEarnings:332,0 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:116,50
MA50:123,33
MA200:111,81
Price/MA200:4,2 %
RSI (14):43,0
Price/MA50:-5,5 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.